Evidence map›Paper›PMID 27490946›Full record

ArticlePloS one2016

Pooled Resequencing of 122 Ulcerative Colitis Genes in a Large Dutch Cohort Suggests Population-Specific Associations of Rare Variants in MUC2.

Marijn C Visschedijk, Rudi Alberts, Soren Mucha, Patrick Deelen, Dirk J de Jong, Marieke Pierik, Lieke M Spekhorst, Floris Imhann, Andrea E van der Meulen-de Jong, C Janneke van der Woude and 13 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 10 institutions in 3 countries.

Marijn C VisschedijkDepartment of Gastroenterology and Hepatology, University of Groningen, University Medical Centre Groningen, 9700 RB, Groningen, The Netherlands.
Rudi AlbertsDepartment of Gastroenterology and Hepatology, University of Groningen, University Medical Centre Groningen, 9700 RB, Groningen, The Netherlands.
Soren MuchaInstitute of Clinical Molecular Biology, Kiel University, D-24105, Kiel, Germany.
Patrick DeelenDepartment of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, 9700 RB, Groningen, The Netherlands.
Dirk J de JongDepartment of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Centre, 6525 GA, Nijmegen, The Netherlands.
Marieke PierikDivision of Gastroenterology and Hepatology, Maastricht University Medical Centre, 6229 HX, Maastricht, The Netherlands.
Lieke M SpekhorstDepartment of Gastroenterology and Hepatology, University of Groningen, University Medical Centre Groningen, 9700 RB, Groningen, The Netherlands.
Floris ImhannDepartment of Gastroenterology and Hepatology, University of Groningen, University Medical Centre Groningen, 9700 RB, Groningen, The Netherlands.
Andrea E van der Meulen-de JongDepartment of Gastroenterology and Hepatology, Leiden University Medical Centre, 2333 ZA, Leiden, The Netherlands.
C Janneke van der WoudeDepartment of Gastroenterology and Hepatology, Erasmus University Medical Centre, 3015 CE, Rotterdam, The Netherlands.
Adriaan A van BodegravenDepartment of Gastroenterology and Hepatology, VU University Medical Centre, 1081 HZ, Amsterdam, The Netherlands.
Bas OldenburgDepartment of Gastroenterology and Hepatology, University Medical Centre Utrecht, 3584 CX, Utrecht, The Netherlands.
Mark LöwenbergDepartment of Gastroenterology and Hepatology, Academic Medical Centre, 1105 AZ, Amsterdam, The Netherlands.
Gerard DijkstraDepartment of Gastroenterology and Hepatology, University of Groningen, University Medical Centre Groningen, 9700 RB, Groningen, The Netherlands.
David EllinghausInstitute of Clinical Molecular Biology, Kiel University, D-24105, Kiel, Germany.
Stefan SchreiberDepartment of Internal Medicine I, University Medical Centre Schleswig-Holstein, Kiel, Germany.
Cisca WijmengaDepartment of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, 9700 RB, Groningen, The Netherlands.
Initiative on Crohn and Colitis
Parelsnoer Institute
Manuel A RivasCentre for the Study of IBD (SCIBD) Genetics, The Broad Institute, Cambridge, Massachusetts, United States of America.
Andre FrankeInstitute of Clinical Molecular Biology, Kiel University, D-24105, Kiel, Germany.
Cleo C van DiemenDepartment of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, 9700 RB, Groningen, The Netherlands.
Rinse K WeersmaDepartment of Gastroenterology and Hepatology, University of Groningen, University Medical Centre Groningen, 9700 RB, Groningen, The Netherlands.
University Medical Center Groningen · NLBroad Institute · USChristian-Albrechts-Universität zu Kiel · DEAmsterdam UMC Location University of Amsterdam · NLAmsterdam UMC Location Vrije Universiteit Amsterdam · NLLeiden University · NLMaastricht University Medical Centre · NLRadboud University Nijmegen · NLUniversity Hospital Schleswig-Holstein · DEUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genome-wide association studies have revealed several common genetic risk variants for ulcerative colitis (UC). However, little is known about the contribution of rare, large effect genetic variants to UC susceptibility. In this study, we performed a deep targeted re-sequencing of 122 genes in Dutch UC patients in order to investigate the contribution of rare variants to the genetic susceptibility to UC. The selection of genes consists of 111 established human UC susceptibility genes and 11 genes that lead to spontaneous colitis when knocked-out in mice. In addition, we sequenced the promoter regions of 45 genes where known variants exert cis-eQTL-effects. Targeted pooled re-sequencing was performed on DNA of 790 Dutch UC cases. The Genome of the Netherlands project provided sequence data of 500 healthy controls. After quality control and prioritization based on allele frequency and pathogenicity probability, follow-up genotyping of 171 rare variants was performed on 1021 Dutch UC cases and 1166 Dutch controls. Single-variant association and gene-based analyses identified an association of rare variants in the MUC2 gene with UC. The associated variants in the Dutch population could not be replicated in a German replication cohort (1026 UC cases, 3532 controls). In conclusion, this study has identified a putative role for MUC2 on UC susceptibility in the Dutch population and suggests a population-specific contribution of rare variants to UC.

Indexed as

Case-Control StudiesColitis, UlcerativeDNAGene FrequencyGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeHigh-Throughput Nucleotide SequencingHumansMucin-2NetherlandsPolymorphism, Single NucleotidePromoter Regions, GeneticQuantitative Trait LociSequence Analysis, DNADNAMUC2 protein, humanMucin-2

Identifiers

PMID27490946
PMCPMC4973970
OpenAlexW2495175497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.